Oxothiazolidinecarboxylic acid

DB12224InvestigationalSmall molecule

Procysteine has been used in trials studying the treatment of HIV Infections.

Chemical structure of Oxothiazolidinecarboxylic acid
Mechanism
Curator reviewed
Formula / weight
C4H5NO3S · 147.15 g/mol (avg)
Also known as
(-)-2-OXO-4-THIAZOLIDINECARBOXYLIC ACID · (R)-2-OXOTHIAZOLIDINE-4-CARBOXYLIC ACID · 2-OXO-4-THIAZOLIDINECARBOXYLIC ACID, L- · 2-OXO-L-THIAZOLIDINE-4-CARBOXYLIC ACID · 4-THIAZOLIDINECARBOXYLIC ACID, 2-OXO-, (R)-

Resolves to

Compound
UNIIX7063P804ECAS19771-63-2ChEMBLCHEMBL442218ChEBI125673PubChem72390
Clinical / RWD
RxNorm1926836
Structure
InChIKeyBMLMGCPTLHPWPY-REOHCLBHSA-NSMILESOC(=O)[C@@H]1CSC(=O)N1
Targets
Q8TDS4HCAR2

What you can answer from here — as of July 07, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
1Clinical trialPhase, status and sponsor resolved per trial
Sign in
3+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Oxothiazolidinecarboxylic acid, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In